AdvaMed® Welcomes White House’s “America’s AI Action Plan”
WASHINGTON, D.C.—Scott Whitaker, president and CEO of AdvaMed, the MedTech Association®, issued the following statement on the White House’s “America’s AI Action Plan”:
AdvaMed® Asks U.S. Court of Appeals to Recognize FDA, CMS, and Health Care Provider Decision-Making Concerning Patient Safety
Washington, DC.—AdvaMed, the MedTech Association®, asked the Court of Appeals for the Third Circuit to vacate the judgment of the District Court, which if allowed to stand, would have significant…
AdvaMed® Statement on the Tax Bill
WASHINGTON – Today, AdvaMed, the MedTech Association®, released the following statement from President and CEO Scott Whitaker on the impact the “One Big Beautiful Bill Act” will have on medtech…
AdvaMed® Welcomes Introduction of American Innovation and Jobs Act
WASHINGTON—AdvaMed, the MedTech Association®, welcomed introduction of the bipartisan Access to Prescription Digital Therapeutics Act of 2025 (S. 1702/H.R. 3288) by U.S. Sens. Shelley Moore Capito (R-W.Va.) and Jeanne Shaheen…
AdvaMed® Welcomes Introduction of Access to Prescription Digital Therapeutics Act
WASHINGTON—AdvaMed, the MedTech Association®, welcomed introduction of the bipartisan Access to Prescription Digital Therapeutics Act of 2025 (S. 1702/H.R. 3288) by U.S. Sens. Shelley Moore Capito (R-W.Va.) and Jeanne Shaheen…
AdvaMed® Welcomes the Re-Introduction of the Ensuring Patient Access to Critical Breakthrough Products Act
Washington, D.C.–AdvaMed President and CEO Scott Whitaker released the following statement upon re-introduction of bipartisan legislation aimed at accelerating Medicare coverage for breakthrough medtech and diagnostics. The Ensuring Patient Access…
Swiss Medtech andAdvaMed® Call for Zero for Zero Tariffs and Recognition of FDA Approvals and Clearances
Bern/Washington – Swiss Medtech, the leading trade association for medical technology companies in Switzerland, andAdvaMed®, the U.S. Medtech Association and the world’s largest organization representing medtech innovators, are jointly calling…
AdvaMed® Testifies in U.S. Senate
WASHINGTON – Today, President and CEO Scott Whitaker of AdvaMed, the MedTech Association®, testified before the U.S. Senate Committee on Finance in its hearing focused on the impact of tariffs…
AdvaMed®, U.K. Medtech Association Call for Flexibility on Tariffs, “Regulatory Convergence”
WASHINGTON—AdvaMed, the MedTech Association®, the world’s largest organization representing medtech innovators, and the Association of British HealthTech Industries (ABHI), the leading trade association for medical technology companies in the United…
AdvaMed® CEO Calls for “Zero for Zero” Reciprocal Tariffs on Medtech with U.S. Trading Partners
WASHINGTON – Scott Whitaker, president and CEO of AdvaMed, the MedTech Association®, today called for a reciprocal “zero for zero” model with respect to tariffs among U.S. trading partners for…